Hans Gühring

1.5k total citations
32 papers, 1.3k citations indexed

About

Hans Gühring is a scholar working on Pharmacology, Physiology and Molecular Biology. According to data from OpenAlex, Hans Gühring has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 9 papers in Physiology and 8 papers in Molecular Biology. Recurrent topics in Hans Gühring's work include Pain Mechanisms and Treatments (9 papers), Inflammatory mediators and NSAID effects (8 papers) and Osteoarthritis Treatment and Mechanisms (6 papers). Hans Gühring is often cited by papers focused on Pain Mechanisms and Treatments (9 papers), Inflammatory mediators and NSAID effects (8 papers) and Osteoarthritis Treatment and Mechanisms (6 papers). Hans Gühring collaborates with scholars based in Germany, United States and Switzerland. Hans Gühring's co-authors include Kay Brune, Mehmet Ateş, Gerd Geißlinger, Irmgard Tegeder, Hanns Ulrich Zeilhofer, May Hamza, Andreas Pahl, Ellen Niederberger, Catherine Ledent and M. Michaelis and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Neuroscience and The FASEB Journal.

In The Last Decade

Hans Gühring

30 papers receiving 1.2k citations

Peers

Countries citing papers authored by Hans Gühring

Since Specialization

Citations

This map shows the geographic impact of Hans Gühring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Gühring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Gühring more than expected).

Fields of papers citing papers by Hans Gühring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Gühring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Gühring. The network helps show where Hans Gühring may publish in the future.

Co-authorship network of co-authors of Hans Gühring

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Gühring. A scholar is included among the top collaborators of Hans Gühring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Gühring. Hans Gühring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibody response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis treated with evobrutinib: A Bruton’s tyrosine kinase inhibitor 2023 ·Multiple Sclerosis Journal ·Amit Bar‐Or, Anne H. Cross, Anthony L. Cunningham, Yann Hyvert, (unknown), Hans Gühring, Elise E. Drouin, Nektaria Alexandri, (unknown), Xavier Montalbán	4
2	R399E, A Mutated Form of Growth and Differentiation Factor 5, for Disease Modification of Osteoarthritis 2022 ·Arthritis & Rheumatology ·Anne Gigout, (unknown), (unknown), Christian Brenneis, Frances Henson, Kyra J. Cowan, Djordje Müsil, Christian S. Thudium, Hans Gühring, M. Michaelis, (unknown)	3
3	Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria 2022 ·Kidney International Reports ·Jonathan Barratt, James A. Tumlin, Yusuke Suzuki, Amy Kao, Aida Aydemir, (unknown), Hulin Jin, Hans Gühring, Gerald B. Appel	67
4	Importance of Osmolarity and Oxygen Tension for Cartilage Tissue Engineering 2020 ·BioResearch open access ·(unknown), M. Michaelis, Hans Gühring, S. Lindemann, Anne Gigout	20
5	SAT0647 MRI DATA FROM THE SPRIFERMIN PHASE II FORWARD STUDY: CONFIRMATION OF MANUAL CARTILAGE SEGMENTATION FINDINGS BY AUTOMATED SEGMENTATION 2019 ·Annals of the Rheumatic Diseases ·Alan Brett, M.A. Bowes, Philip G. Conaghan, C. Ladel, (unknown), Hans Gühring, Flavie Moreau, F. Eckstein	2
6	OP0092 Identification of Pain Subtypes Associated with Placebo-Response: Data from Two Phase 3 Randomized Clinical Trials in Symptomatic Knee Osteoarthritis 2016 ·Annals of the Rheumatic Diseases ·Asger Reinstrup Bihlet, M.A. Karsdal, I. Byrjalsen, Anne‐Christine Bay‐Jensen, (unknown), J.R. Andersen, Hans Gühring, C. Ladel, M. Michaelis, B.J. Riis, Ivo Valter	1
7	Labyrinthopeptine – eine neue Klasse carbacyclischer Lantibiotika 2010 ·Angewandte Chemie ·K. Meindl, Timo Schmiederer, Kathrin Schneider, Andreas Reicke, Diane Butz, Simone Keller, Hans Gühring, László Vértesy, Joachim Wink, Holger Hoffmann, Mark Brönstrup, George M. Sheldrick, Roderich D. Süßmuth	26
8	Labyrinthopeptins: A New Class of Carbacyclic Lantibiotics 2010 ·Angewandte Chemie International Edition ·K. Meindl, Timo Schmiederer, Kathrin Schneider, Andreas Reicke, Diane Butz, Simone Keller, Hans Gühring, László Vértesy, Joachim Wink, Holger Hoffmann, Mark Brönstrup, George M. Sheldrick, Roderich D. Süßmuth	177
9	Intrathecally applied flurbiprofen produces an endocannabinoid‐dependent antinociception in the rat formalin test 2003 ·European Journal of Neuroscience ·Mehmet Ateş, May Hamza, Kay Seidel, (unknown), Catherine Ledent, Hans Gühring	65
10	The cannabinoids R(−)-7-hydroxy-delta-6-tetra-hydrocannabinol-dimethylheptyl (HU-210), 2-O-arachidonoylglycerylether (HU-310) and arachidonyl-2-chloroethylamide (ACEA) increase isoflurane provoked sleep duration by activation of cannabinoids 1 (CB1)-receptors in mice 2002 ·Neuroscience Letters ·(unknown), Mehmet Ateş, Kay Brune, Hans Gühring	16
11	A role for endocannabinoids in indomethacin-induced spinal antinociception 2002 ·European Journal of Pharmacology ·Hans Gühring, May Hamza, Marina Sergejeva, Mehmet Ateş, (unknown), Catherine Ledent, Kay Brune	108
12	Modulation of Synaptic Transmission by Nociceptin/Orphanin FQ and Nocistatin in the Spinal Cord Dorsal Horn of Mutant Mice Lacking the Nociceptin/Orphanin FQ Receptor 2001 ·Molecular Pharmacology ·Seifollah Ahmadi, (unknown), Hans Gühring, Hiroshi Takeshima, Andreas Pahl, Hanns Ulrich Zeilhofer	40
13	HU-210 shows higher efficacy and potency than morphine after intrathecal administration in the mouse formalin test 2001 ·European Journal of Pharmacology ·Hans Gühring, (unknown), May Hamza, Mehmet Ateş, (unknown), Kay Brune	27
14	Role of nitric oxide in zymosan induced paw inflammation and thermal hyperalgesia 2001 ·Inflammation Research ·Hans Gühring, Irmgard Tegeder, Jörn Lötsch, Andreas Pahl, Ulrike Werner, Peter W. Reeh, Klaus Rehse, Kay Brune, Gerd Geißlinger	47
15	Inhibition of NF‐ κ B and AP‐1 activation by R‐ and S‐flurbiprofen ¹ ² 2001 ·The FASEB Journal ·Irmgard Tegeder, Ellen Niederberger, (unknown), Hans Gühring, Kay Brune, Christian Euchenhofer, Sabine Grösch, Gerd Geißlinger	119
16	Modulation of Synaptic Transmission by Nociceptin/Orphanin FQ and Nocistatin in the Spinal Cord Dorsal Horn of Mutant Mice Lacking the Nociceptin/Orphanin FQ Receptor 2001 ·Molecular Pharmacology ·Seifollah Ahmadi, (unknown), Hans Gühring, Hiroshi Takeshima, Andreas Pahl, Hanns Ulrich Zeilhofer	1
17	Effects of Selective and Unselective Cyclooxygenase Inhibitors on Prostanoid Release from Various Rat Organs 2000 ·Journal of Pharmacology and Experimental Therapeutics ·Irmgard Tegeder, W. M. Neupert, Hans Gühring, Gerd Geißlinger	42
18	Selective Suppression of Inhibitory Synaptic Transmission by Nocistatin in the Rat Spinal Cord Dorsal Horn 2000 ·Journal of Neuroscience ·Hanns Ulrich Zeilhofer, (unknown), Hans Gühring, Katharina Erb, Seifollah Ahmadi	68
19	Muscle Damping Measured With a Modified Pendulum Test in Patients With Fibromyalgia, Lumbago, and Cervical Syndrome 1996 ·Spine ·(unknown), (unknown), Hans Gühring, Thierry Ettlin, (unknown), Wolfgang Müller	18
20	[Comments on a letter]. 1992 ·PubMed ·Hans Gühring	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact